Skip to content

Role of Vitamin D And Calcium supplementation on breast cancer receiving chemotherapy

To study the role of Vitamin D and calcium supplementation on tumor response in patients receiving neoadjuvant chemotherapy for stage II/III breast cancer- A comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040878
Enrollment
35
Registered
2022-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C501- Malignant neoplasm of central portion of breast Health Condition 3: C500- Malignant neoplasm of nipple and areola Health Condition 4: C508- Malignant neoplasm of overlappingsites of breast

Interventions

Intervention1: Vitamin D and Calcium: With Blinding, Study Group Will Be Supplemented With 50000 IU Vitamin D Once Weekly For One Month And Tab Calcium 500 Mg BD Daily For The Entire Chemotherapy D

Sponsors

King George Medical University UP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Naïve Stage II/III breast cancer patients consenting for NACT.

Exclusion criteria

Exclusion criteria: 1. Patients with osteoporosis and parathyroid disorders. 2. Patients not consenting for chemotherapy.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of vitamin d and calcium on tumor response by supplementing it during neoadjuvant chemotherapy in breast cancerTimepoint: at the end of 4 cycles of chemotherapy

Secondary

MeasureTime frame
To evaluate the effect of Vitamin D and calcium supplementation during chemotherapy in breast cancer patients on Neutrophil to lymphocytes ratio [NLR] Amelioration of toxic side effects quality of Life.Timepoint: at the end of 4 cycles of chemotherapy

Countries

India

Contacts

Public ContactSukesh KS

King George Medical University UP

saisukeshks@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026